The article discusses on the benefits, risks and uncertainties on Prostate Specific Antigen (PSA) test for prostate cancer screening. It states that a PSA test is uncertain, wherein only a prostate biopsy can confirm the present of cancer but it is a procedure with several after effects and ...
To determine your Gleason score, a pathologist will look at your prostate biopsy tissue under a microscope. They are looking to see what shape the cells are, how big they are, and what the internal structures look like. They do this because cancer cells change over time as they continue to...
Transrectal ultrasound-guided prostate biopsy was performed after 18–24 mo and every 2 yr thereafter. Treatment was recommended for \\{PSA\\} velocity (... Elizabeth,D.,Selvadurai,... - 《European Urology》 被引量: 144发表: 2013年
Multiparametric prostate magnetic resonance imaging (mpMRI)–guided fusion prostate biopsy is an emerging technique in the diagnosis of prostate cancer and provides extensive information on the prebiopsy anatomy of the prostate, anus, and rectum. We aimed to investigate the clinical and anatomical risk...
et al. Comparing the Gleason Prostate Biopsy and Gleason Prostatectomy Grading System: The Lahey Clinic Medical Center experience and an international meta-analysis. Eur. Urol. 54, 371–381 (2008). PubMed Google Scholar Baciarello, G., Gizzi, M. & Fizazi, K. Advancing therapies in ...
With low-risk cancer, one option is to watch and wait. This is determined by your biopsy, PSA test, and Gleason scores. Your doctor will order periodic testing. Other treatments -- with the risk of sexual or urinary problems -- may not be necessary. Some men who are older or have ser...
Nam RK, Zhang WW, Jewett MA, Trachtenberg J, Klotz LH, Emami M, Sugar L, Sweet J, Toi A, Narod SA: The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Clinical cancer research: an official journal of the American Association for Cancer Research. 2005, ...
scores, no controlling for those scores has taken place. From each csPCa patient, the chosen CT scan will be the closest scan to the biopsy (a maximum of 6 months prior, or 6 weeks after the biopsy to allow the prostate to heal visible signs (with a maximum of 3 months post biopsy)...
Post-treatment biopsy of the injected lesions indicated that tumor cell apoptosis correlated with HSV-1 TK expression and CAR levels. Of 11 subjects, 1 (9%) exhibited a reduction of more than 50% in serum PSA after treatment; however, this event lasted less than 2 weeks. There were no ...
sensitivity of the HADS in the context of prostate cancer testing. In addition, a longitudinal Dutch screening study reported no significant adverse effects on psychological health after receipt of a negative biopsy result (Essink-Bot et al, 1998). This study used a general measure for anxiety,...